ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,944,993 | -0.5% | 212,995 | -5.1% | 0.04% | +9.4% |
| Q2 2023 | $20,038,442 | -22.2% | 224,519 | -6.5% | 0.03% | -25.6% |
| Q1 2023 | $25,755,849 | -15.8% | 240,215 | -4.1% | 0.04% | -17.3% |
| Q4 2022 | $30,602,112 | +15.8% | 250,570 | -2.1% | 0.05% | +10.6% |
| Q3 2022 | $26,426,000 | +7.8% | 255,928 | -3.0% | 0.05% | +14.6% |
| Q2 2022 | $24,513,000 | -22.2% | 263,709 | -1.8% | 0.04% | +2.5% |
| Q1 2022 | $31,521,000 | -15.1% | 268,595 | -2.7% | 0.04% | -2.4% |
| Q4 2021 | $37,123,000 | – | 275,953 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |